Pedro Politi
@pedropoliti.bsky.social
Medical oncologist (Argentina and US NCI). Retired Pharmacology Professor.
The true “wizard” of Oz.
March 14, 2025 at 10:37 PM
The true “wizard” of Oz.
Priapism should be short lived. If not, go to ER.
December 18, 2024 at 12:57 AM
Priapism should be short lived. If not, go to ER.
It was about time!
December 18, 2024 at 12:52 AM
It was about time!
Correlation versus causation.
December 4, 2024 at 7:30 PM
Correlation versus causation.
There are established pre-emptive combos for chemotherapy-induced nausea/vomiting, depending on emetic risk of the chemo regimen: dexamethasone + ondansetron for moderate risk; dexa + ondansetron + aprepitant for high risk (high doses, full-dose Cisplatin, doxorubicin/cyclophosphamide)
December 4, 2024 at 7:27 PM
There are established pre-emptive combos for chemotherapy-induced nausea/vomiting, depending on emetic risk of the chemo regimen: dexamethasone + ondansetron for moderate risk; dexa + ondansetron + aprepitant for high risk (high doses, full-dose Cisplatin, doxorubicin/cyclophosphamide)
Let’s ask Louis Pasteur 😏
December 3, 2024 at 11:55 AM
Let’s ask Louis Pasteur 😏
Reposted by Pedro Politi
Clearly, induction chemo is a lot less expensive than adding pembrolizumab.
But we have no sense yet on which approach is better.
The details of who benefitted in each do not overlap so I think that can help determine approach. 6/7
But we have no sense yet on which approach is better.
The details of who benefitted in each do not overlap so I think that can help determine approach. 6/7
November 27, 2024 at 12:26 PM
Clearly, induction chemo is a lot less expensive than adding pembrolizumab.
But we have no sense yet on which approach is better.
The details of who benefitted in each do not overlap so I think that can help determine approach. 6/7
But we have no sense yet on which approach is better.
The details of who benefitted in each do not overlap so I think that can help determine approach. 6/7
“The dose makes the poison” Paracelsus
November 27, 2024 at 8:36 PM
“The dose makes the poison” Paracelsus
Not much excited about dexrazoxane: it may interfere with doxorubicin antitumor activity.
November 27, 2024 at 8:30 PM
Not much excited about dexrazoxane: it may interfere with doxorubicin antitumor activity.
Favorite reversal strategy in cancer patients! Start low, go slow.
November 27, 2024 at 2:59 PM
Favorite reversal strategy in cancer patients! Start low, go slow.
Making it affordable is the next huge step.
November 23, 2024 at 6:33 PM
Making it affordable is the next huge step.
“The dose makes the poison” Paracelsus, circa 1500.
November 21, 2024 at 5:39 PM
“The dose makes the poison” Paracelsus, circa 1500.
Bottled mate? Oh, my!
November 20, 2024 at 9:23 PM
Bottled mate? Oh, my!
Limited to BZD and delirium: www.researchgate.net/publication/...
(PDF) Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit: DEPRESCRIBING TO REDUCE DELIRIUM IN THE ICU
PDF | Objective Benzodiazepines and anticholinergics are risk factors for delirium in the intensive care unit (ICU). We tested the impact of a... | Find, read and cite all the research you need on Res...
www.researchgate.net
November 20, 2024 at 11:31 AM
Limited to BZD and delirium: www.researchgate.net/publication/...
Found one: rbfhss.org.br/sbrafh/artic...
Deprescribing medicines in an intensive care unit of a university hospital from Ceará
| Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Revista Brasileira de Farmacia Hospitalar e Serviços de Saúde is the official journal of the Brazilian Society of Hospital Pharmacy
rbfhss.org.br
November 20, 2024 at 11:27 AM
Found one: rbfhss.org.br/sbrafh/artic...
Hope this helps: amp.cancer.org/cancer/types...
Breast Cancer Statistics | How Common Is Breast Cancer?
Read the American Cancer Society’s latest information and statistics for breast cancer in women in the United States.
amp.cancer.org
November 19, 2024 at 11:06 PM
Hope this helps: amp.cancer.org/cancer/types...